These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1605617)

  • 21. Paradoxical enhancement of the activity of a bacterial multidrug transporter caused by substitutions of a conserved residue.
    Klyachko KA; Neyfakh AA
    J Bacteriol; 1998 Jun; 180(11):2817-21. PubMed ID: 9603866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.
    Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ
    Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of Bacillus subtilis membrane protein Bmr: an in silico approach.
    Nargotra A; Rukmankesh ; Ali S; Koul S
    Curr Comput Aided Drug Des; 2014; 10(3):226-36. PubMed ID: 25756668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus.
    Noguchi N; Okada H; Narui K; Sasatsu M
    Microb Drug Resist; 2004; 10(3):197-203. PubMed ID: 15383162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain.
    Markham PN; Ahmed M; Neyfakh AA
    J Bacteriol; 1996 Mar; 178(5):1473-5. PubMed ID: 8631728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus.
    Huang J; O'Toole PW; Shen W; Amrine-Madsen H; Jiang X; Lobo N; Palmer LM; Voelker L; Fan F; Gwynn MN; McDevitt D
    Antimicrob Agents Chemother; 2004 Mar; 48(3):909-17. PubMed ID: 14982783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus.
    Truong-Bolduc QC; Dunman PM; Strahilevitz J; Projan SJ; Hooper DC
    J Bacteriol; 2005 Apr; 187(7):2395-405. PubMed ID: 15774883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three transport systems for the osmoprotectant glycine betaine operate in Bacillus subtilis: characterization of OpuD.
    Kappes RM; Kempf B; Bremer E
    J Bacteriol; 1996 Sep; 178(17):5071-9. PubMed ID: 8752321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of
    Bhaskar BV; Babu TM; Reddy NV; Rajendra W
    Drug Des Devel Ther; 2016; 10():3237-3252. PubMed ID: 27757014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of substrate exposure and other growth condition manipulations on norA expression.
    Kaatz GW; Seo SM
    J Antimicrob Chemother; 2004 Aug; 54(2):364-9. PubMed ID: 15231765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.
    Neyfakh AA; Bidnenko VE; Chen LB
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4781-5. PubMed ID: 1675788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
    Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
    Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda.
    de Sousa Andrade LM; de Oliveira ABM; Leal ALAB; de Alcântara Oliveira FA; Portela AL; de Sousa Lima Neto J; de Siqueira-Júnior JP; Kaatz GW; da Rocha CQ; Barreto HM
    Microb Pathog; 2020 Mar; 140():103935. PubMed ID: 31857236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciphering the Molecular Recognition Mechanism of Multidrug Resistance
    Palazzotti D; Bissaro M; Bolcato G; Astolfi A; Felicetti T; Sabatini S; Sturlese M; Cecchetti V; Barreca ML; Moro S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial multidrug efflux: introduction.
    Paulsen IT; Lewis K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):143-4. PubMed ID: 11321565
    [No Abstract]   [Full Text] [Related]  

  • 38. A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus.
    Fournier B; Truong-Bolduc QC; Zhang X; Hooper DC
    J Bacteriol; 2001 Apr; 183(7):2367-71. PubMed ID: 11244079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis.
    Sheridan RP; Chopra I
    Mol Microbiol; 1991 Apr; 5(4):895-900. PubMed ID: 1906966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The YjbH adaptor protein enhances proteolysis of the transcriptional regulator Spx in Staphylococcus aureus.
    Engman J; Rogstam A; Frees D; Ingmer H; von Wachenfeldt C
    J Bacteriol; 2012 Mar; 194(5):1186-94. PubMed ID: 22194450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.